Indian Pharmaceutical Market Grows 12.1% in Value in July 2026
The Indian Pharmaceutical Market (IPM) grew 12.1% in value in July 2026, reaching sales of approximately Rs 23,193 crore. Growth was driven by chronic therapies, with cardiac and anti-diabetic segments posting double-digit increases. Other notable segments included gastrointestinal, anti-infectives, vitamins, respiratory, and neuro CNS therapies. Value growth was supported by pricing, new products, and volume increases, while unit growth remained modest at around 1.6%. Leading brands like Eli Lilly's Mounjaro showed significant sales growth, reflecting market expansion across multiple therapy areas.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (63/100). Lens Score 37/100.
Outlets measured: thetribune, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (58–68/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 7 Aug, 03:11 pm. Other outlets followed.